The latest updates and insights for health researchers. We share stories from our research partners, best practices, and product updates. Subscribe to the Greenlight newsletter here.
In three consecutive articles published in On The Risk throughout 2025, Munich Re Life documented the effectiveness of EHR data in more than 800 underwriting cases across multiple carriers and every major evidence scenario. It’s the most comprehensive independent validation to date—and the findings are clear: EHR data reduces underwriting time and cost.
In Part 1 of this series, we covered the three forces that have made EHR data viable for insurance: regulatory enforcement, national exchange infrastructure, and modern interoperability standards. The access problem is largely solved. But access was never really the...
Welcome Tom McCarthy! We are pleased to announce that Tom McCarthy has joined Greenlight Health Data Solutions as an Advisor. With over 40 years of experience across leading carriers and reinsurance companies, including 17 years at Swiss Re, Tom brings...
In a rapidly evolving healthcare data landscape, we explore EHR trends for underwriters and why these developments finally make EHR evidence underwriting-grade. For more than a decade Electronic Health Records (EHRs) have promised to improve efficiency in life insurance underwriting....
Greenlight Health Data Solutions Announced a Partnership with Kno2, a Federally Designated QHIN, to Expand TEFCA-enabled, Patient-directed Health Data Exchange Nationwide.
Greenlight Health Data Solutions launches Intelligent Health Data Platform.
IWQOL-Lite-CT© (Impact of Weight on Quality of Life-Lite-Clinical Trials) is the gold standard patient-reported outcome (PRO) measure of weight-related quality of life in adults designed for use in clinical trials. As the exclusive licensor of IWQOL-Lite-CT©, Greenlight works with CROs and biopharma organizations to implement the measure for regulated clinical trials.
Clinical trial sponsors are constantly seeking ways to accelerate study timelines, thereby more rapidly delivering therapeutics to patients and optimizing return on R&D investment. Accelerating clinical trials means acquiring high-quality data faster. It means developing protocols, configuring technology, activating research...
The evaluation of value-based payment (VBP) models over the past decade has shown mixed results. While there have been some improvements in spending and quality, the models have not significantly advanced health outcomes or sustainable spending at scale. To drive...
The U.S. Department of Health and Human Services (HHS), through its Office for Civil Rights, has announced a $200,000 civil monetary penalty against Oregon Health & Science University (OHSU) for failing to provide timely access to an individual’s medical records,...
The introduction of patient portals in the early 2010s as part of the Meaningful Use initiative was met with significant resistance from healthcare providers, including CIOs, CFOs, and clinicians. They expressed concerns about cost, infrastructure, and increased workload. Today, these...
The rapid advancement of artificial intelligence (AI) in medicine is paving the way for the potential development of artificial general intelligence (AGI), a revolutionary technology capable of understanding and solving complex medical problems with human-like proficiency. However, regulatory challenges, particularly...
